Bio-Rad Laboratories (BIO) Operating Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Operating Expenses data on file, last reported at $275.3 million in Q1 2026.

• On a quarterly basis, Operating Expenses fell 2.48% year-over-year to $275.3 million in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 0.18% change from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 0.9% from the prior year.
• Operating Expenses for Q1 2026 stood at $275.3 million, down from $291.3 million in the prior quarter.
• Over the last five years, Operating Expenses for BIO reached as high as $300.5 million in Q1 2023 and fell as low as $244.7 million in Q3 2023.
• Historically, Operating Expenses has averaged $275.2 million across 5 years, with a median of $277.9 million in 2022.
• Across the five-year window, Operating Expenses slipped 14.52% in 2022 and grew 19.07% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $278.4 million in 2022, then fell by 2.66% to $271.0 million in 2023, then increased by 4.65% to $283.6 million in 2024, then increased by 2.72% to $291.3 million in 2025, then declined by 5.49% to $275.3 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $275.3 million in Q1 2026, $291.3 million in Q4 2025, and $278.1 million in Q3 2025.